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A B S T R A C T
In vivo and in vitro evidence from animals suggesting that gap junctions (GJs) play a role in the spreading
of epileptiform activity. We have examined the inﬂuence of the gap junction opener trimethylamine
(TMA) and the connexin 36 (Cx36) gap junctional blocker, quinine, on epileptiform activity induced by 4-
aminopyridine (4-AP) in the rat entorhinal cortex (EC) and the CA1 hippocampal region. A cannula and
surface electrodes were implanted into the brain to administer drugs and to monitor electrical activity.
Injection of 4-AP (10 nmol) produced epileptiform discharge trains of high amplitude and frequency
associated with seizure behavior rated between 0 and 3 in the Racine scale. In the presence of TMA
(500 nmol), 4-AP produced distinct epileptiform patterns with continuous, long epileptiform discharges
of high amplitude and frequency associated with seizure behavior of 0, 1, 3 and 5 during the ﬁrst 30 min
post-drug administration that diminished after 90 min. Quinine injection (35 pmol) into the EC of seizing
animals decreased the amplitude and frequency of the discharge trains in the EC and CA1 regions, which
were completely blocked after 34 min. Indeed, the seizure behavior of the animals was completely
blocked in ﬁve of the six rats 53.2 s after quinine administration. We suggest that the intensity of the
proepileptic effect of TMA on epileptiform activity depends on the time and route of drug administration,
and that neural Cx36-dependent GJs are important structures in the generation of epileptiform activity,
as well as in the seizure behavior induced by 4-AP.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy is a neuronal disorder that affects people worldwide,
which may reﬂect the imbalance in the excitatory and inhibitory
activity of neurons.1,2 Recently, gap junctions (GJs) were proposed
to participate in seizure activity on the basis of electrophysiologi-
cal, pharmacological and molecular evidence obtained in vitro3–7
and in vivo.8–10 Indeed, GJ blockers such as carbenoxolone and
quinine, as well as openers such as trimethylamine (TMA), display
antiepileptiform and proepileptiform effects, respectively.4,8–14
4-Aminopyridine (4-AP) is an agent that promotes convulsions
by blocking K+ channels, thereby prolonging action potentials in
neurons and facilitating the non-speciﬁc release of neurotrans-
mitters. Moreover, this agent may also induce synaptic glutamate
release in some regions,2,15 and it was suggested that such as
increase in extracellular glutamate may provoke the overactiva-
tion of postsynaptic excitatory glutamate receptors, thereby* Corresponding author at: Departamento de Biologı´a Celular yMolecular, Centro
Universitario de Ciencias Biolo´gicas y Agropecuarias, Universidad de Guadalajara,
45110 Guadalajara, Jalisco, Mexico. Tel.: +52 33 37771191x3201;
fax: +52 33 37771171.
E-mail address: lmedina@cucba.udg.mx (L. Medina-Ceja).
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.07.009inducing seizures and convulsive behavior. However, low con-
centrations of 4-AP also produce epileptiform activity without
affecting glutamate levels,16,17 which led us to think of alternative
mechanisms to provoke seizures in the 4-AP model, such as
through GJs.
Some in vivo studies have examined the inﬂuence of agents that
alter GJ activity in the 4-AP model, producing both antiepileptic
and proepileptic effects. However, such studies have concentrated
on neocortical structures and they have been performed on
anesthetized animals.8,9 We previously found that carbenoxolone,
a blocking agent that non-speciﬁcally binds to and closes GJ
channels, decreases the amplitude and frequency of epileptiform
activity, as well as dampening seizure behavior induced by 4-AP in
the rat entorhinal cortex (EC) and hippocampus.10 These limbic
structures are important sites for seizure generation, and GJs in
CA1 pyramidal neurons (non-principal neurons, such as hippo-
campal interneurons) may play an important role in the
hypersynchronization of this epileptiform activity.6,10,18 Accord-
ingly, we set out to further examine this hypothesis by analyzing
the effects of quinine (a speciﬁc Cx36 GJ blocker) and TMA (a GJ
opener that causes intracellular alkalinization) in the EC and the
CA1 hippocampal region of 4-AP treated rats, and to determine
whether TMA exerts a synergistic effect in this model. We
examined the effects of these drugs on speciﬁc EEG parameters,vier Ltd. All rights reserved.
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activity, as well as their inﬂuence on seizure behavior of 4-AP
treated rats. The results obtained provide further insight into the
participation of GJs in epileptiform activity.
2. Materials and methods
2.1. Animals
Twenty-six adult male Wistar rats (250–350 g) were used in
these experiments, in a manner designed to minimize the number
of animals. Animals were housed in a temperature regulated room
with free access to food and water, and on a 12-h day/12-h night
cycle. This study conformed to the Rules for Health Research
Matters (Mexico) and it was approved by the local Animal Care
Committee.
2.2. Surgery
The animals were ﬁrst anesthetizedwith isoﬂuorane in 100% O2
and secured in a Stoelting stereotaxic frame with the incisor bar
positioned at 3.3 mm. A stainless steel guide cannula (0.5 mm
internal diameter) was implanted into each rat through a hole
drilled in the skull, positioned at the stereotaxic coordinates of the
right EC (EC: AP = 8 mm, L = 4.6 mm and V = 4 mm from the
bregma). A cannula was used to insert an injection needle
(V = 5 mm) that also served as a recording electrode and, it was
insulated by varnishing the whole surface but the ﬁnal 1 mm
portion from its tip. In addition, three stainless steel screws were
driven into the bone, two above the bregma and one above the
cerebellum, which served as indifferent and ground electrodes,
respectively. One surface electrode, with the same characteristics
as the electrodes mentioned above, was implanted into the skull
above the right CA1 region of the hippocampus (AP = 5.6 mm and
L = 5.0 mm from the bregma) and it was also used as a recording
electrode. The guide cannula and surface electrode wires were
attached to a socket connector and ﬁxed to the skull with acrylic
dental cement.
2.3. Animal groups and drug administration
After surgery, the animals were allowed to recover for 24 h and
they were divided into three control and two experimental groups
as follows: (a) a group that was administered a dose of 10 nmol 4-
AP (n = 6); (b) a group of animals that received two injections of
NaCl (0.9%) and TMA (a 500 nmol dose) at different times, 30 min
and 220 min after the EEG recording was initiated (n = 3); (c) a
group of rats that received a dose of 35 pmol quinine injection
(n = 5); (d) an experimental group that received an injection of 4-
AP and TMA (n = 6); and (e) an experimental group of animals that
received 4-AP and an injection of quinine 30 min after the
epileptiform pattern was established (n = 6).
All the drugswere obtained from Sigma (St. Louis,MO, USA) and
they were administered into the EC. The 4-AP was injected at the
appropriate concentration of NaCl to maintain iso-osmolarity. All
drugs were injected at a ﬂow rate of 0.2 ml/min for 5 min (ﬁnal
volume 1ml) using a microsyringe mounted on a BAS microinjec-
tion pump and they were all diluted in saline solution.
2.4. EEG recording
The rats were placed in a container unit and connected to a
cable thatwas ﬁxed to a balanced arm. The EEGwas recorded using
a Grass polygraph with a low-frequency ﬁlter at 1 Hz and a high-
frequency ﬁlter at 300 Hz, sampled at 100 Hz/channel (two
channels). The data were stored on a computer hard disk andanalyzed with PolyView 2.1 software. After a 30 min period of
recording basal activity, the ﬁrst group of animals received a 4-AP
injection (10 nmol) and they were then observed continuously for
approximately 120 min during EEG recordings. The other control
and experimental groups were recorded for 30 min as the basal
period before the drugs were administered, and for 90 min after
treatment. These animals were also observed continuously. The
basal electrical activity of all groups of animals was analyzed,
averaging the amplitude and frequency during a period of 3 min
along the recording.
To understand the effects of TMA and quinine on epileptiform
activity in this seizuremodel, the datawere analyzed bymeasuring
the amplitude of single epileptiform discharges during a 1 min
period at different times after drug administration. The frequency
of the EEG epileptiform activity (the number of single epileptiform
discharges during a one second seizure period) was averaged
manually for 1 min according to the different times studied.
Propagation of this epileptiform activity to the CA1 region through
the hippocampus–entorhinal cortex circuit was also analyzed.
2.5. Behavioral study
In general, the behavior of all the rats in the control and
experimental groups was studied by continuous observation
before, during and after drug administration. The Racine scale
was used to assess the animals19 with minor modiﬁcations to
adapt it to this seizure model as follows10: 0, behavioral arrest
(motionless), hair raising, excitement and rapid breathing; 1,
movement of the mouth lips and tongue, vibrissae movement and
salivation; 2, head clonus and eye clonus; 3, forelimb clonus, ‘‘wet
dog shakes’’; 4, clonic rearing; 5, clonic rearingwith loss of postural
control and uncontrollable jumping.
2.6. Histological evaluation
The location of the guide cannula was veriﬁed after each
experiment. For this purpose, the animals were anesthetized with
sodium pentobarbital, transcardially perfused with 100 ml of
normal saline (0.9%) in 0.12 M buffer/CaCl2, followed by 300 ml of
4% paraformaldehyde in 0.12 M buffer/CaCl2 [pH 7.3]. The animal’s
brain was then removed, and coronal sections (50mm thick) were
obtained and stained with cresyl violet. Animals in which the
cannula did not reach the exact position required were not
included in the study.
2.7. Data analysis
The results are shown as the mean (SEM), and the comparisons
between the control and experimental groups were performed using
the Mtab13 statistical software package applying an one-way
analysis of variance (ANOVA) with a Tukey–Kramer post hoc test.
Statistical signiﬁcance was considered at p < 0.05.
3. Results
The basal EEG activity of the control animals that received NaCl,
4-AP, TMA and quinine was generally characterized by physiologi-
cal slowwaves of low amplitude and frequency, similar to the basal
EEG activity in the experimental groups (Figs. 1A, B and C, and 4C).
The group of rats that received an injection of 4-AP into the EC
developed epileptiform activity that was initially characterized by
hypersynchronous activity followed by trains of poly-spikes. The
low amplitude and frequency spike-wave complexes observed in
these animals increased during the experiment, and almost
immediately propagated to the CA1 region (latency to the ﬁrst
epileptiform discharge EC 21  8.02 s, CA1 75.7  27.3 s: Fig. 1B).
Fig. 1. Representative EEG recordings fromcontrol and experimental rats inwhich different drugswere injected into the EC. These recordings showthe basal activity during and at
different timesafterdrugadministration. (A)Nochanges inEEGactivitywereobservedineither theECorCA1regionsafterNaCl0.9%injection. (B)Therecordingsshowepileptiform
activityofhighamplitudeand frequencyafter4-AP injection(10 nmol) inboth theECandCA1duringtheentireexperiment(120min). (C)Nochanges inEEGactivitywereobserved
after TMA injection (500 nmol) in the ECandCA1 regions studied. (D)After 4-AP/TMAco-injection into the EC, epileptiformactivityofhighamplitude and frequencywas evident in
both the EC and CA1 regions and this activity persisted throughout the experiment (90 min). It is important to note the different calibration bars in the ﬁgure.
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region of the hippocampus
No signiﬁcant changes in EEG activity were observed during the
experiment in the control groups that received NaCl and TMA
(Fig. 1A and C). However, when 4-AP was co-injected with TMAFig. 2. The graphs represent the mean (SEM) of the different EEG amplitudes and frequen
injected rats, during basal activity, after drug administration (5 min after basal activity was r
4-AP/TMA injection. Symbols represent: * vs. saline group; * vs. TMA group; and * vs. 4into the EC, epileptiform discharges of high amplitude and
frequency were observed in the EC and CA1 region for up to
90 min (Fig. 1D). There were no signiﬁcant differences in the
epileptiform activity between this experimental group of animals
and the control group that received 4-AP alone, except for a
signiﬁcant decrease in the frequency of epileptiform discharges incy parameters in the EC and CA1 of the three control groups, and the 4-AP and TMA co-
egistered and when the drugs had been fully administered), and 90 min after 4-AP and
-AP group. CG, control group and EG, experimental group.
L. Medina-Ceja, C. Ventura-Mejı´a / Seizure 19 (2010) 507–513510the CA1 region 90 min after co-injection of 4-AP/TMA (Fig. 2). By
contrast, signiﬁcant differences in amplitude and frequency were
observed in the EC and CA1 regions of these experimental animals
with respect to the electrical activity in the saline and TMA control
rats (Fig. 2). Moreover, there was a tendency toward a decrease in
the amplitude of epileptiform activity in both the EC and CA1
regions 90 min after 4-AP/TMA co-injection in these experimental
animals (Fig. 2). Furthermore, 4-AP/TMA co-injection modiﬁed the
typical epileptiform pattern observed after 4-AP administration in
the EC region. Thus, rather than a train of epileptiform discharges,
continuous extended epileptiform activity (status epilepticus) was
observed in both regions studied (Fig. 3A and B). In four of the six
rats, these epileptiform discharges were observed in the EC region
but not in the CA1 region of hippocampus (Fig. 3C).
3.2. Effect of quinine on seizure activity in the EC and CA1 region of the
hippocampus
No signiﬁcant differences in electrical activity were observed in
the saline and quinine control groups (Fig. 4A and C). When 4-AP
was administered to the experimental group, a classical epilepti-
form pattern was observed in both the EC and CA1 regions,
although there was a signiﬁcant reduction in the frequency of the
epileptiform discharges in the CA1 of these experimental animals
when compared with 4-AP control group (Figs. 4 and 5). Injection
of quinine 30 min after 4-AP in these seizing animals, decreased
the amplitude and frequency of the epileptiform discharges in the
EC and CA1 regions, and such discharges were completely blockedFig. 3. (A) Representative EEG recordings of a 4-AP treated rat showing the
epileptiform discharge trains and in an expanded trace marked by the bar, an
epileptiform discharge train of high amplitude in the injected EC region. (B) 4-AP/
TMA co-injection into the EC produced continuous epileptiform activity that is
evident in the recordings and in an expanded trace. (C) In four of the six rats this
continuous epileptiform activitywas only evident in the EC region. It is important to
note the different calibration bars in the ﬁgure.34  4.3 min after quinine administration, with no further recurrence
for the duration of the recording (90 min, Fig. 5). This antiepileptiform
effect of quinine was signiﬁcant, both immediately following the
injection aswell as 90 min after quinine administration, in the regions
of the seizing animals studied (Fig. 5).
3.3. Effect of trimethylamine and quinine on seizure behavior
The 4-AP treated rats were attributed a rating of 0, 1 and 3 in the
modiﬁed Racine scale during the experiment (120 min). Two of six
rats also received a score of 2 in the scale (Table 1A). According to
this scale, there was no seizure behavior in the rest of the control
animals, and they only presented sporadic tidying and scratching
activity before and after drug administration.
Co-injection of 4-AP/TMA produced a rating of 0, 1, 3 and 5
during the ﬁrst 30 min after administration, although a score of 5
was observed in two of the six rats. The animalswere still rated as 0
and 1 on this scale at the end of the experiment, although 120 min
after co-injection of the drugs, one rat was still attributed a score of
3 (Table 1B).
Finally, quinine injection in 4-AP treated rats decreased seizure
behavior, which was completely blocked in ﬁve of six rats at
53.2  10.5 s. Indeed, only one animal remained with a rating of 1 in
the modiﬁed scale at the end of the experiment (90 min post-quinine
injection), although the scores of this rat had tended to decrease from
3 to 1 over the last 60 min after the quinine injection (Table 1C).
4. Discussion
In this work, 4-AP (10 nmol) administration to the EC produced
epileptiform activity characterized by high amplitude and
frequency discharge trains. This activity propagated to the CA1
region almost simultaneously and it was correlated with seizure
behavior rated as 1, 2 and 3 according to themodiﬁed Racine scale.
We found certain variation in the basal electrical activity, as well in
the epileptiform activity in different control and experimental
groups, which is probably due to the individual variability between
subjects and the fact that the experiments were carried out at
different times according to the availability of the animals. There is
evidence that 4-AP administration to rats preferably increases
extracellular glutamate levels in the hippocampus,2 suggesting
that this drug might induce seizures through the hyperactivation
of postsynaptic glutamate receptors.1,15 However, low concentra-
tions of 4-AP can produce epileptiform activity without affecting
glutamate levels.16,17 Hence, 4-AP may generate seizures by an
alternative mechanism unrelated to chemical synapses, although
we cannot rule out the participation of neurotransmitter systems
other than glutamate.
Many studies have found that GJs between cells in the CNS
participate in epileptiform activity in several in vitro models,4,18
some GJ blockers and openers demonstrating antiepileptic and
proepileptic activity, respectively.4,7,11,13,18 Indeed, carbenoxolone
and quinine are non-speciﬁc and speciﬁc GJ blockers that display
antiepileptic activity,9,10 while the GJ opener TMA exerts a
proepileptic effect in some in vivo studies.8,20
In this study, 4-AP/TMA co-injection into the EC region of
vigilant animals produced epileptiform discharges of high ampli-
tude and frequency that persisted throughout the experiment
(90 min), and that were similar to those obtained in animals that
received 4-AP alone. However, in four of six rats this epileptiform
activity was only observed in the EC region and the frequency of
epileptiform activity decreased throughout the experiment in both
regions studied, as did the seizure behavior score. During the
experiment the classical pattern of epileptiform activity found in
our previous study,10 involving epileptiform discharge trains of
high amplitude and frequency, changed to a pattern of continuous
Fig. 4. Representative EEG recordings from rats treated with different drugs: (A) NaCl (0.9%); (B) 4-AP (10 nmol); (C) quinine (35 pmol). No changes in the EEG activity were
observed in either the EC or the CA1 of NaCl and quinine treated animals. The 4-AP injection induced a classic epileptiformpattern characterized by epileptiform discharges of
high amplitude and frequency in both the EC and CA1 regions. (D) Quinine administration 30 min after 4-AP injection decreased the amplitude and frequency of epileptiform
activity, and these seizure discharges were completely blocked in the experimental group 34  4.3 min after quinine injection. It is important to note the different calibration
bars in the ﬁgure. The data in A and B are from the same rats as in Fig. 1A and B.
Fig. 5. The graphs represent the mean (SEM) of the different EEG amplitudes and frequency parameters from the EC and CA1 of control and quinine treated rats injected 30 min
after 4-AP administration, during basal activity, after drug administration (5 min after basal activity was registered and when the drugs had been fully administered), 30 and
120 min post-drug injection in control animals and post-quinine administration, as well as 90 min after quinine injection in the experimental group. Symbols represent * vs. saline
group * vs. quinine group and * vs. 4-AP group, CG control group and EG experimental group.
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Table 1
Seizure behavior of three groups of rats that received different drug injections in the EC region: (A) rats injected with 4-AP (10nmol, n=6); (B) 4-AP/TMA co-injected animals
(10 and 500nmol, respectively; n=6); (C) 4-AP treated rats injected with quinine 30min after epileptiform pattern was established (35pmol, n=6). The symbol * represents
the time period when no more changes in seizure behavior were observed, according the modiﬁed Racine scale.
(A)
Rat Behavior after 4-AP injection
0–20 (min) 20–40 (min) 40–60 (min) 120 (min)
1 0/1/3 3 1/3 1/3
2 0/1/3 3 2/3 1/3
3 0/3 0/1/3 0/1/2/3 0/1/3
4 0/1/3 0/1/3 0/1/3 0/1/3
5 0/1/3 0/3 0/1/3 0
6 0/1 0/1/3 0/1/3 1
(B)
Rat Behavior After 4-AP/TMA co-injection
0–10 (min) 10–30 (min) 30–50 (min) 50–70 (min) 70–90 (min) 90–110 (min) 110–120 (min) *
1 0/1 1/3 0/1/3 1/3 0/1/3 0/1 0 78
2 0/3/5 0/1/3 0/1/3 0/1/3 0/1/3 1 1 90
3 0/1/3 0/1/3 3 3 0/1/3 0/1 1 95
4 0/1/3 0/3 0/3 0/3 0/3 0/3 3 120
5 0/1/3 0/1/3 0/3 0/1/3 0 0 0 80
6 0/1/3 0/3/5 0/1 0/1/3 0/1/3 0/1 0 90
(C)
Rat Behavior after 4-AP 0–30 (min) Behavior after quinine 0–10 (min) 10–30 (min) 30–50 (min) 50–70 (min) 70–90 (min) *
1 0/1/2/3 3 0/1/3 1/3 1/3 – 83
2 1/3 0/1 0/1/3 1 – – 60
3 0/1/3 0/1/3 0/1/2/3 1 1 1 90
4 0/1/2/3 0/1/3 0/1 – – – 36
5 0/1/2/3 0/3 0/3 0/3 – – 57
6 0/1/3 0/3 0/3 – – – 30
The values represent different seizure behavior according to the modiﬁed Racine scale: 0, behavioral arrest (motionless), hair raising, excitement and rapid breathing; 1,
mouth movement of lips and tongue, vibrissae movement, and salivation; 2, head clonus and eye clonus; 3, forelimb clonus, ‘‘wet dog shakes’’; 4, clonic rearing; 5, clonic
rearing with loss of postural control and uncontrollable jumping. The symbol ‘‘–’’ represents no convulsive behavior.
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the ﬁrst 30 min after of 4-AP and TMA administration, this
epileptiform activity was associated with seizure behavior that
was classiﬁedwith a score of 0, 1, 3 and 5 according to themodiﬁed
Racine scale, although a score of 5 was only observed in two of the
six rats. These data differ from earlier studies,8,9 where TMA
increased the duration and amplitude of seizures induced by 4-AP
in the neocortex of anesthetized rats, facilitating seizure propaga-
tion. In these earlier studies, the drugs like 4-APwere administered
via ﬁlters placed directly onto the neocortex and these ﬁlters
remained in place throughout the experiment (continued drug
delivery), which might have facilitated the proepileptic effect of
this drug. Using this protocol of drug administration it is not
possible to precisely control the exact dose of the drug adminis-
tered. By contrast, the administration of 4-AP and TMA into the EC
was carefully regulated here (ﬂow rate: 0.2 ml/min for 5 min) and
ﬁnal doses of 10 and 500 nmol, respectively, were applied.
Therefore, we propose that local injection of a speciﬁc dose of
4-AP and TMA, coupled with the short administration times used
heremight explain the differences in the data found between these
studies. Although TMA reverts the anticonvulsant properties of
quinine in the pentylenetetrazole model,20 no changes in the
latency to the ﬁrst generalized tonic–clonic seizure were found
when TMA was administrated at different doses 40 min before
pentylenetetrazole. These latter results are in agreement with our
data, since we did not ﬁnd any pro-convulsive synergistic effect of
TMA, even when 4-AP and TMA were delivered together.
Nevertheless, we did observe an interesting change since the
classic pattern of epileptiform activity induced by 4-AP was
modiﬁed to continuous epileptiform discharges, while the
convulsive behavior of some of the animals in this group shifted
from a rating of 3–5 in the modiﬁed Racine scale, only during the
ﬁrst 30 min after co-injection of 4-AP and TMA. In the light of theseresults, we highlight the importance of considering that the effects
of TMA in the 4-AP model depend on the dose and method of drug
administration. We cannot rule out the fact that other non-
synaptic mechanisms also play a role in 4-AP induced seizures,
such as electric ﬁeld effects or ionic interactions,3 or other
neurotransmitter systems not related to glutamate.
Quinine speciﬁcally blocks Cx36, yet at low concentrations
quinine can also block ATP-sensitive and voltage-dependent K+
channels, as well as nicotinic and cholinergic receptors, and at high
concentrations it affects Cx45 GJs and IP3-induced Ca
2+ release.21
Nevertheless, in vitro studies demonstrated that quinine did not
affect basal electric activity and neuronal excitability.24,25 A
speciﬁc dose of quinine that selectively blocks Cx36 proteins
localized in the GJs of neurons was used here,21 and this
administration of quinine produced a decrease in the amplitude
and frequency of the epileptiform discharge trains induced by 4-
AP. In addition, it completely blocked seizure activity in both the
EC and CA1 regions. Furthermore, quinine administration blocked
animal seizure since only one rat remained with a score of 1 in the
modiﬁed Racine scale. These results are in agreement with other
studies where quinine application decreased the convulsive
activity induced by 4-AP, penicillin or pentylenetetrazole in
animals.9,14,20 Previously,8 quinine has been administered to the
neocortex of anesthetized animals at a concentration of 35mM in a
continous release paradigm, while in other studies,14 the
anticonvulsive effect of quininewas dose-dependentwhen applied
to the frontal and parietal cortex (from 200 to 400 or 1000 nmol).
Here, we observed an anticonvulsive effect of quinine when
injected during a short time period into the EC, even at the lowest
doses tested (35 pmol), as well as in the epileptiform activity
propagated to the CA1. This result led us to contemplate the
participation of GJs in neurons during epileptiform activity, as in
the motor activity behind the effects of 4-AP.
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seizuremodel where the effects of TMA and quinine administration
on EEG activity in the EC have been assessed in vigilant animals.
Previous studies have analyzed the effects of these drugs in
vitro4,7,11,13,18 and the available in vivo studies have been carried
out on anesthetized animals or alternatively, the drugs have been
administered to other brain regions, such as the cortex.8,9,12,14 GJ
communication between interneurons in the hippocampus is
thought to inﬂuence their behavior.3,6,22 Moreover, 4-AP induces
synchronized discharges that can be blocked by GABAA receptor
antagonists,17,23 which might be related to the hypersynchroniza-
tion of GABAergic interneurons during epileptiform activity. These
data support the hypothesis that the contribution of GJsmight favor
the hypersynchronization of epileptiform activity induced by 4-AP
between different types of interneurons in the EC and CA1 regions
studied here. We cannot rule out the inﬂuence of the coupling of
interneurons throughGJs andglutamate transmission in this seizure
model, which might participate in the generation and maintenance
of epileptiform activity at high 4-AP concentrations. Indeed, it is
possible that GJs located in neurons from these regions may
contribute to seizures after the injection of low4-AP concentrations.
Recent experimental evidence indicates that glutamate may be
released through hemichannels or connexons (components of GJs)
and that this release mechanism is functional in astrocytes within
the nervous system.26–28 We cannot ignore this possibility since a
similar mechanism of glutamate release at low 4-AP concentra-
tions might produce seizures in vivo. Nevertheless, the levels
ofglutamate released by this mechanism may not be sufﬁcient to
be detected by classical techniques.We are currentlyworkingwith
a novel device that permits glutamate to be measured in small
fractions with a better time resolution in order to study this
hypothesis.29
Finally, the present results sustain the belief that the effect of
TMA on epileptiform activity, as well as on seizure behavior,
depends on the duration and route of drug administration. We
conclude that coupling GABAergic interneurons and principal
neurons by GJs, both in the EC and CA1 hippocampal regions could
synchronize epileptiform activity at the site of generation, as well
as in other propagated brain areas. GJs are also important
structures in the generation of seizure behavior induced by 4-AP
in the regions studied. Given that the low dose of quinine does not
alter EEG activity or the behavior of rats, we suggest that the use of
this speciﬁc GJ blockermay pave theway for new strategies to treat
seizures, as observed in this model of experimental epilepsy.
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